Release Date: 02/09/14 12:34 Summary: Removal from Official Quotation - Correction Price Sensitive: Yes Download Document 25.74KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%